Crispr Therapeutics Ag (CRSP)

Working Capital Ratio

84.46%

Quarterly · Period ending:

CRSP logo

CRSP Working Capital Ratio

Latest reported84.46%
CRSP Quarterly Working Capital Ratio (92.01% → 84.46%)
High-resolution chart · PNG

CRSP working capital ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Crispr Therapeutics Ag Working Capital Ratio — Quarterly
Period endingWorking Capital Ratio
84.4613%
84.8213%
80.6407%
80.6186%
80.2727%
80.7055%
82.4854%
82.1797%
80.4574%
82.0262%
80.701%
79.0362%
78.5946%
78.4709%
77.2124%
75.7146%
80.6661%
82.3782%
83.4932%
85.8599%
86.9461%
89.3437%
88.7523%
87.9983%
85.1491%
86.7861%
87.2219%
81.0844%
82.3602%
84.6397%
89.7003%
89.4984%
88.372%
90.0203%
86.1903%
87.3016%
87.0468%
86.7227%
86.4414%
55.1058%
57.5174%
52.4714%
92.0099%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.